Harvard Health Letter

Biologic therapy doesn't raise cancer risk in people with rheumatoid arthritis

Despite theoretical reasons to worry that biologic response modifiers may raise cancer risk, it appears they don’t significantly raise the risk of malignancy. The drugs can dramatically improve inflammation in people with rheumatoid arthritis.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »